PT3615036T - Preparação de um extrato de 20-hidroxiecdisona de qualidade farmacêutica - Google Patents

Preparação de um extrato de 20-hidroxiecdisona de qualidade farmacêutica

Info

Publication number
PT3615036T
PT3615036T PT187210422T PT18721042T PT3615036T PT 3615036 T PT3615036 T PT 3615036T PT 187210422 T PT187210422 T PT 187210422T PT 18721042 T PT18721042 T PT 18721042T PT 3615036 T PT3615036 T PT 3615036T
Authority
PT
Portugal
Prior art keywords
hydroxyecdysone
grade
pharmaceutical
extract
preparation
Prior art date
Application number
PT187210422T
Other languages
English (en)
Original Assignee
Biophytis
Univ Sorbonne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophytis, Univ Sorbonne filed Critical Biophytis
Publication of PT3615036T publication Critical patent/PT3615036T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06Anabolic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
PT187210422T 2017-04-28 2018-04-30 Preparação de um extrato de 20-hidroxiecdisona de qualidade farmacêutica PT3615036T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1753775A FR3065644B1 (fr) 2017-04-28 2017-04-28 Extrait de 20-hydroxyecdysone de qualite pharmaceutique, son utilisation et sa preparation
FR1758071A FR3065642B1 (fr) 2017-04-28 2017-08-31 Utilisation de 20-hydroxyecdysone et ses derives dans le traitement des myopathies

Publications (1)

Publication Number Publication Date
PT3615036T true PT3615036T (pt) 2024-02-27

Family

ID=59381456

Family Applications (2)

Application Number Title Priority Date Filing Date
PT187195839T PT3615035T (pt) 2017-04-28 2018-04-27 Utilização de 20-hidroxiecdisona e os seus derivados no tratamento de miopatias
PT187210422T PT3615036T (pt) 2017-04-28 2018-04-30 Preparação de um extrato de 20-hidroxiecdisona de qualidade farmacêutica

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT187195839T PT3615035T (pt) 2017-04-28 2018-04-27 Utilização de 20-hidroxiecdisona e os seus derivados no tratamento de miopatias

Country Status (12)

Country Link
US (2) US11542295B2 (pt)
EP (2) EP3615035B1 (pt)
JP (2) JP7295806B2 (pt)
KR (2) KR102652803B1 (pt)
CN (2) CN110769832B (pt)
BR (1) BR112019022392A2 (pt)
DK (1) DK3615036T3 (pt)
ES (2) ES2882571T3 (pt)
FR (2) FR3065644B1 (pt)
PL (2) PL3615035T3 (pt)
PT (2) PT3615035T (pt)
WO (2) WO2018197708A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3065644B1 (fr) * 2017-04-28 2020-02-21 Biophytis Extrait de 20-hydroxyecdysone de qualite pharmaceutique, son utilisation et sa preparation
FR3078252B1 (fr) * 2018-02-28 2020-08-14 Biophytis Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation
CZ309080B6 (cs) * 2018-12-19 2022-01-19 Karel Dr. Sláma Způsob stanovení rizika vzniku maligních nádorů
FR3093640B1 (fr) * 2019-03-15 2021-10-01 Biophytis Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement de maladies neuromusculaires
FR3093641B1 (fr) * 2019-03-15 2023-11-03 Biophytis Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement de l’altération de la fonction respiratoire
FR3108504B1 (fr) * 2020-03-30 2023-03-31 Biophytis Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement d’altérations de la fonction respiratoire lors d’une infection virale
CN113208962B (zh) * 2021-05-10 2024-07-02 江苏省中国科学院植物研究所 一种鹿草提取物、制备方法及其应用
FR3143975B1 (fr) 2022-12-23 2025-10-24 Biophytis Phytoecdysones pour leur utilisation dans le traitement de pathologies respiratoires inflammatoires
FR3157102A1 (fr) 2023-12-22 2025-06-27 Biophytis Compositions de phytoecdysones pour leur administration par voie intranasale
FR3158880A1 (fr) 2024-02-01 2025-08-08 Biophytis Phytoecdysones et/ou dérivés de 20-hydroxyecdysone en combinaison avec un agoniste de GLP-1 pour leur utilisation dans le traitement de l’obésité et du surpoids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38540A0 (en) * 1971-01-18 1972-03-28 Dauten Sa Method for the extraction of insect moulting steroid hormones
CN1353113A (zh) 2001-11-29 2002-06-12 沈阳药科大学 中药牛膝有效部位及其制剂与医药用途和制备方法
WO2011127398A2 (en) * 2010-04-08 2011-10-13 The Arizona Board Of Regents On Behalf Of The University Of Arizona In vitro cellular bioassay for neurotoxicity testing
FR3021318B1 (fr) * 2014-05-20 2017-04-28 Inst Biophytis Produits derives de la 20-hydroxyecdysone et leur utilisation dans la preparation de medicaments
US9700589B2 (en) * 2015-02-03 2017-07-11 Naturex Sa Compositions and methods for improved muscle metabolism
FR3065644B1 (fr) * 2017-04-28 2020-02-21 Biophytis Extrait de 20-hydroxyecdysone de qualite pharmaceutique, son utilisation et sa preparation

Also Published As

Publication number Publication date
KR102652803B1 (ko) 2024-04-01
CN110753547A (zh) 2020-02-04
EP3615036B1 (fr) 2023-11-22
KR20200012871A (ko) 2020-02-05
EP3615036A1 (fr) 2020-03-04
JP7165143B2 (ja) 2022-11-02
CN110753547B (zh) 2024-05-14
JP7295806B2 (ja) 2023-06-21
DK3615036T3 (da) 2024-02-12
PT3615035T (pt) 2021-08-20
KR102593901B1 (ko) 2023-10-26
ES2882571T3 (es) 2021-12-02
US11542295B2 (en) 2023-01-03
WO2018197731A1 (fr) 2018-11-01
EP3615035B1 (fr) 2021-06-09
EP3615035A1 (fr) 2020-03-04
FR3065642B1 (fr) 2020-02-28
PL3615036T3 (pl) 2024-06-10
FR3065644B1 (fr) 2020-02-21
ES2971226T3 (es) 2024-06-04
WO2018197708A1 (fr) 2018-11-01
BR112019022379A2 (pt) 2020-05-19
US20200179407A1 (en) 2020-06-11
CN110769832A (zh) 2020-02-07
US20200148718A1 (en) 2020-05-14
FR3065644A1 (fr) 2018-11-02
PL3615035T3 (pl) 2021-12-20
JP2020517697A (ja) 2020-06-18
BR112019022392A2 (pt) 2020-05-19
FR3065642A1 (fr) 2018-11-02
JP2020517712A (ja) 2020-06-18
CN110769832B (zh) 2023-08-01
KR20200005574A (ko) 2020-01-15

Similar Documents

Publication Publication Date Title
PT3615036T (pt) Preparação de um extrato de 20-hidroxiecdisona de qualidade farmacêutica
IL274276A (en) CASZ preparations and methods of use
GB2582100B (en) CAS12C Compositions and methods of use
IL266017B (en) Arylimidazole isoxazoles, their preparation, their preparations and their uses
IL266560A (en) Endophytes, related preparations and methods of using them
PL3668937T3 (pl) Kompozycje i zastosowania Z-1-chloro-2,3,3,3-tetrafluoroprop-1-enu
ZA201801511B (en) Flavonoid compositions and methods of use
SI3580561T1 (sl) Metode, osnovane na hla, in njihove sestave ter uporabe
CA3244408A1 (en) Therapeutic compositions, combinations, and methods of use
HUE065438T2 (hu) Vegyületek, készítmények és alkalmazási eljárások
IL254831A0 (en) Conjugates containing ursodeoxycholic, berberine or l-carnitine, preparations containing them and their uses
EP3161124A4 (en) Endophytes, associated compositions, and methods of use thereof
ZA201906169B (en) Synthekine compositions and methods of use
PL3373910T3 (pl) Preparat echinomycyny, sposób wytwarzania i sposób stosowania
EP3125914A4 (en) Compositions comprising cyclocarya paliurus extract and preparation method and uses thereof
ZA201906326B (en) Analogs of deutetrabenazine, their preparation and use
EP3166649A4 (en) Aqueous extract of truffle and cosmetic composition thereof
IL274166A (en) Cannabinoid compounds and their uses
IL266840A (en) History of tyrosine and preparations containing them
EP3282857A4 (en) Human milk compositions and methods of making and using same
IL272834A (en) Compositions of amantadine, their preparation, and methods of use
PL3568419T3 (pl) Polibutadien, jego wytwarzanie i zastosowanie
IL273988A (en) Compounds of cannabidiol and chitosan, and methods for their use
EP3253396A4 (en) Probiotic compositions and methods of use
SG11202002351SA (en) Poloxamer compositions and methods of making and using same